Certified by Founder Lodge
Deerfield Management
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $24,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We seek to advance healthcare through investment, information and philanthropy. At Deerfield, we owe our success to our team-oriented process, which brings together many decades of experience
| Company | Date | Round | Raised |
|---|---|---|---|
 Epic Sciences |
April, 17 ,2023 | Unknown | $24,000,000 |
 Cortica |
April, 19 ,2023 | Unknown | $75,000,000 |
 Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
 Ray Therapeutics, Inc. |
May, 17 ,2023 | Series A | $100,000,000 |
 Presidio Medical, Inc. |
June, 27 ,2023 | Series C | $72,000,000 |
 Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
 Actio Biosciences, Inc. |
September, 15 ,2023 | Series A | $55,000,000 |
 Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
 Cohere Health |
February, 06 ,2024 | Unknown | $50,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
4D Biomaterials | $4,373,097 | (Jul 26, 2024)
TRiCares GmbH | $50,000,000 | (Jul 26, 2024)
Micropep Technologies | $29,000,000 | (Jul 26, 2024)
GEOH | $3,000,000 | (Jul 26, 2024)
SirenOpt | $6,600,000 | (Jul 26, 2024)
